Clinical Trial Update: Oral Microdose Lupron Versus Luteal Estradiol Trial in Poor Responder In Vitro Fertilization (IVF) Patients [Phase 4]

View source ↗

Summary

Phase 4 IVF trial comparing oral microdose leuprolide (Lupron) to luteal estradiol in poor-responder IVF patients has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Infertility

Drugs mentioned

• ESTRADIOL (Estradiol)
• Lupron (leuprolide)

Snippet

Sponsor: Weill Medical College of Cornell University | Conditions: Infertility | Phase 4 | Status: WITHDRAWN